Imagin Molecular Corporation (OTCBB:IMGM), recently announced that the Company has formed a wholly owned subsidiary, Imagin Nuclear Partners (INP) that will operate PET business joint ventures.

Rimonabant Report to Cover All of the Latest Rimonabant Trial Results and Related News Briefings at American College of Cardiology Meeting in Orlando